CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini on Monday, April 29th. As previously communicated, the Immucor assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list are now available on our website.
On August 9, 2019, the new CTS Laboratory Information System was successfully implemented in St...
Reminder test emails for the Health and Human Services (HHS) email notifications for WNV reactives h...
The CTS forms listed below have been revised with an implementation date of September 2, 2019. ...
At CTS, we understand the impact converting to the Ortho viral marker platform has on your operation...
CTS Tampa has implemented the Ortho Vitros Anti-SARS-CoV-2 Total test which qualitatively detects an...
The Q & A document from the Reentry Changes Webinar hosted on 06/06/18 has been posted in the Wh...